Internal Medicine, Pulmonary Disease · Atlanta, GA
NPI
1841222833
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1365 Clifton Rd NE, Building A, Suite A 4331
Atlanta, GA, 30322
Phone (404) 712-2970
Groups this clinician bills Medicare through
Medicare paid, 2024
$14K
281 services
Medicare patients, 2024
55
Average age 72
Drug cost, 2024
$2.7M
2,177 prescriptions
Company payments, 2025
$8,587
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Frances E Lee was code 99215 (office e&m - established), 52 times for 34 patients. In total Frances E Lee billed 281 services in 18 codes, and Medicare paid $14K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-06-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 52 | 34 | $131.70 | $6,848 |
| 94375 Pulmonary Function Testing | Office | 48 | 37 | $21.81 | $1,047 |
| 95012 Pulmonary | Office | 24 | 23 | $14.05 | $337 |
| 99214 Office E&M - Established | Office | 24 | 20 | $64.17 | $1,540 |
| 94726 Pulmonary Function Testing | Office | 15 | 13 | $28.54 | $428 |
| 94729 Pulmonary Function Testing | Office | 11 | 11 | $31.70 | $349 |
By year: 2022 $65K for 714 services; 2023 $37K for 419 services; 2024 $14K for 281 services.
Medicare prescription drug claims, 2024
In 2024, the drug Frances E Lee prescribed most often to Medicare patients was Dupixent Pen (Dupilumab), with 200 prescriptions and refills. In total Frances E Lee wrote 2,177 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Dupixent Pen Dupilumab | 200 | 204 | 23 | $742K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 184 | 205 | 67 | $4,260 |
| Montelukast Sodium Generic | 177 | 493 | 58 | $1,678 |
| Fluticasone Propionate Generic | 107 | 214 | 47 | $1,555 |
| Nucala Mepolizumab | 103 | 103 | 14 | $622K |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 100 | 143 | 26 | $17K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 99 | 147 | 21 | $91K |
| Azelastine Hcl Generic | 87 | 183 | 41 | $3,139 |
| Symbicort Budesonide/Formoterol Fumarate | 87 | 163 | 25 | $36K |
| Advair Hfa Fluticasone Propion/Salmeterol | 85 | 109 | 22 | $40K |
| Xolair Omalizumab | 84 | 90 | Under 11 | $299K |
| Prednisone Generic | 82 | 102 | 46 | $385 |
| Fasenra Pen Benralizumab | 65 | 107 | 13 | $359K |
| Breo Ellipta Fluticasone/Vilanterol | 51 | 69 | 14 | $27K |
| Famotidine Generic | 43 | 89 | 11 | $406 |
Brand drugs: 1,301 claims; generic drugs: 876 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Frances E Lee $8,587 ($8,587 in general payments such as food, travel and fees) from 5 companies. The largest payer was Novartis Pharmaceuticals Corporation with $8,587.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 6 | $8,587 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.